Three-year equity sale reached with Dutchess Opportunity Cayman Fund
By Devika Patel
Knoxville, Tenn., April 14 - iCo Therapeutics Inc. said it negotiated a C$10 million equity line facility.
The three-year agreement was arranged with Dutchess Opportunity Cayman Fund Ltd.
Based in Vancouver, B.C., iCo Therapeutics is a development-stage specialty pharmaceutical company focused on the reprofiling and repositioning of drugs and drug candidates with a clinical history for new disease indications.
| Issuer: | iCo Therapeutics Inc.
|
| Issue: | Equity line facility
|
| Amount: | C$10 million
|
| Tenor: | Three years
|
| Warrants: | No
|
| Investor: | Dutchess Opportunity Cayman Fund Ltd.
|
| Pricing date: | April 14
|
| Stock symbol: | TSX Venture: ICO
|
| Stock price: | C$0.33 at close April 13
|
| Market capitalization: | C$13.55 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
